| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Diagnostic Program for Patients Suspected of Having Lung Cancer
|
Stigt, Jos A.
|
|
2012
|
13 |
6 |
p. 475-481
7 p.
|
artikel
|
| 2 |
A Multicenter Phase II Study of Adjuvant Chemotherapy With Oral Fluoropyrimidine S-1 for Non–Small-Cell Lung Cancer: High Completion and Survival Rates
|
Tsuchiya, Tomoshi
|
|
2012
|
13 |
6 |
p. 464-469
6 p.
|
artikel
|
| 3 |
A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non–Small-Cell Lung Cancer
|
Felip, Enriqueta
|
|
2012
|
13 |
6 |
p. 432-441
10 p.
|
artikel
|
| 4 |
A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non–Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment Rationale and Study Design
|
Garon, Edward B.
|
|
2012
|
13 |
6 |
p. 505-509
5 p.
|
artikel
|
| 5 |
Chemotherapy is Beneficial for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Patients Aged 70-74, 75-79, and 80 or Older in Japan
|
Kawaguchi, Tomoya
|
|
2012
|
13 |
6 |
p. 442-447
6 p.
|
artikel
|
| 6 |
Diffuse Reflectance Spectroscopy: A New Guidance Tool for Improvement of Biopsy Procedures in Lung Malignancies
|
Evers, Daniel J.
|
|
2012
|
13 |
6 |
p. 424-431
8 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2012
|
13 |
6 |
p. A2-
1 p.
|
artikel
|
| 8 |
hTERT Gene Amplification and Clinical Significance in Pleural Effusions of Patients With Lung Cancer
|
Cha, Na
|
|
2012
|
13 |
6 |
p. 494-499
6 p.
|
artikel
|
| 9 |
Knockdown of the Epidermal Growth Factor Receptor Gene to Investigate Its Therapeutic Potential for the Treatment of Non–Small-Cell Lung Cancers
|
Shien, Kazuhiko
|
|
2012
|
13 |
6 |
p. 488-493
6 p.
|
artikel
|
| 10 |
Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption
|
Hollevoet, Kevin
|
|
2012
|
13 |
6 |
p. 470-474
5 p.
|
artikel
|
| 11 |
Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients
|
Ferroni, Patrizia
|
|
2012
|
13 |
6 |
p. 482-487
6 p.
|
artikel
|
| 12 |
Primary Pleuropulmonary Sarcoma: A Rare Disease Entity
|
Giaj Levra, Matteo
|
|
2012
|
13 |
6 |
p. 399-407
9 p.
|
artikel
|
| 13 |
Prospective Study of Gefitinib Readministration After Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer Who Previously Responded to Gefitinib
|
Koizumi, Tomonobu
|
|
2012
|
13 |
6 |
p. 458-463
6 p.
|
artikel
|
| 14 |
Role of Hormone Receptor Expression in Patients With Advanced-Stage Lung Cancer Treated With Chemotherapy
|
Monica, Valentina
|
|
2012
|
13 |
6 |
p. 416-423
8 p.
|
artikel
|
| 15 |
Socioeconomic Disparities in Lung Cancer Treatment and Outcomes Persist Within a Single Academic Medical Center
|
Yorio, Jeffrey T.
|
|
2012
|
13 |
6 |
p. 448-457
10 p.
|
artikel
|
| 16 |
Table of Contents
|
|
|
2012
|
13 |
6 |
p. A3-A5
nvt p.
|
artikel
|
| 17 |
The Role of Endobronchial Ultrasound in Lung Cancer Diagnosis and Staging: A Comprehensive Review
|
Kokkonouzis, Ioannis
|
|
2012
|
13 |
6 |
p. 408-415
8 p.
|
artikel
|
| 18 |
Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer
|
Spigel, David R.
|
|
2012
|
13 |
6 |
p. 500-504
5 p.
|
artikel
|
Tijdschrift beschrijving